These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11061780)

  • 1. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cholesterol in adults with phenylketonuria.
    Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
    Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Möller HE; Ullrich K; Weglage J
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S121-5. PubMed ID: 11043158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
    Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N
    Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
    Waisbren SE; Noel K; Fahrbach K; Cella C; Frame D; Dorenbaum A; Levy H
    Mol Genet Metab; 2007; 92(1-2):63-70. PubMed ID: 17591452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review.
    Brumm VL; Azen C; Moats RA; Stern AM; Broomand C; Nelson MD; Koch R
    J Inherit Metab Dis; 2004; 27(5):549-66. PubMed ID: 15669671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria.
    Randell EW; Lehotay DC
    Clin Biochem; 1996 Apr; 29(2):133-8. PubMed ID: 8601321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU).
    Sijens PE; Oudkerk M; Reijngoud DJ; Leenders KL; de Valk HW; van Spronsen FJ
    Eur Radiol; 2004 Oct; 14(10):1895-900. PubMed ID: 15378255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.